Retrospective Study
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Pediatr. Mar 9, 2022; 11(2): 151-159
Published online Mar 9, 2022. doi: 10.5409/wjcp.v11.i2.151
Barriers and challenges affecting parents’ use of adrenaline auto-injector in children with anaphylaxis
Hassib Narchi, Ahmed Elghoudi, Klithem Al Dhaheri
Hassib Narchi, Ahmed Elghoudi, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 17666, United Arab Emirates
Ahmed Elghoudi, Department of Pediatrics, Sheikh Khalifa Medical City, Abu Dhabi 51900, United Arab Emirates
Ahmed Elghoudi, Child Health Institute, Al Ain Hospital, Al Ain 1006, United Arab Emirates
Klithem Al Dhaheri, Department of Pediatric, Tawam Hospital, Al Ain 15258, United Arab Emirates
Author contributions: Elghoudi A designed the research protocol, sought ethical approval, collected the data, and was involved in writing the manuscript; Narchi H conducted the statistical analyses, constructed the tables and the graph, and participated in writing the manuscript; Dhaheri KA participated in data collection and writing the manuscript; all authors read and approved the final manuscript.
Institutional review board statement: The study was reviewed and approved by Al Ain Hospital Ethical Research Committee Review board (reference number AAHHEC-01-20-001).
Institutional animal care and use committee statement: No animals were involved in the study.
Informed consent statement: Signed informed consent was obtained from all parents who participated in the study.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest to disclose.
Data sharing statement: The anonymised data can be obtained from the principal investigator (ahmed.elghoudi1@gmail.com) upon reasonable request.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ahmed Elghoudi, MBB Ch, MSc, Doctor, Department of Pediatric, Sheikh Khalifa Medical City, Al Karama Street, Abu Dhabi 51900, United Arab Emirates. ahmed.elghoudi1@gmail.com
Received: April 13, 2021
Peer-review started: April 13, 2021
First decision: July 27, 2021
Revised: August 2, 2021
Accepted: January 19, 2022
Article in press: January 19, 2022
Published online: March 9, 2022
Processing time: 329 Days and 14.2 Hours
ARTICLE HIGHLIGHTS
Research background

Food allergy is common in the paediatric age group and food allergic reactions commonly occur in the community. The adrenaline auto-injector (AAI), issued to groups of children at risk of anaphylaxis, remains the first and only drug of choice for treating anaphylaxis. However, data from different parts of the world demonstrate that AAI is underused by parents and caregivers. The rationale behind this attitude is multilateral and could be attributed to issues such as poor training on the use of the auto-injector device, not understanding when it should be used, and both fear and anxiety of using it.

Research motivation

From our daily observations in the local paediatric allergy clinic, we found many cases of anaphylaxis that occurred at home due to the ingestion of offending food, and parents opted to call 999 or bring the child to the emergency department rather than using the AAI prescribed at the scene. Obviously, underuse of the AAI can put the affected child at risk of severe morbidity or mortality. In every clinic, we reviewed the indication for use of the AAI by parents and provided a visual demonstration on how to use it.

Research objectives

To study the attitude of parents of children at risk of anaphylaxis with regard to the use of AAI in an attempt to identify what prevents these parents from using the AAI when needed. The results of this research would help professionals to be more focused on certain issues when providing counselling and training on the use of the AAI to this cohort of parents.

Research methods

Parents of children with previous or potential anaphylaxis who have been issued with an AAI were requested to complete a paper questionnaire on their understanding of the indications for use of the AAI, competence in using the device, confidence and empowerment in using it in stressful emergency situations.

Research results

The vast majority of parents admitted receiving good and informative training on using the device and demonstrated good knowledge on its indications. However, that was not enough to provide them with the confidence and courage to use the device due to other factors such as anxiety, fear, or not wanting to hurt the child with the AAI needle. Psychological uneasiness in using the device can limit parents’ ability to use it.

Research conclusions

In addition to routine training in these groups of parents on the indication of using the AAI and the technique on how to use it, health professionals need to pay attention to the psychological factor which could prevent these parents from underusing the device when needed. Psychological, behavioural therapy and needle phobia desensitisation would help to overcome the barriers of phobia and anxiety which could interfere with sound decision-making in the treatment of their children in emergency situations.

Research perspectives

Parent training on the use of AAI should be structured and focused. Audio-visual tools should be available in the clinic to help with training. However, the fear factor and the psychological status of these parents should not be overlooked. A routine referral or referral of selected cases to the local psychological service should be accessible to these parents. Play therapists can also have an important role in both children and parents by reducing needle phobia when present.